'We'll create a scientific powerhouse': Pfizer defends AstraZeneca takeover bid

Pfizer has defended its campaign to snap up AstraZeneca in Britain’s biggest foreign takeover claiming the £63 billion deal would create a “scientific powerhouse”.

The US drugmaker also hit back at politicians’ claims that its statement on UK jobs was not "watertight" as bosses from the two companies prepare to be grilled in Parliament tomorrow and on Wednesday.

In its select committee submissions, Pfizer said of its pledge to keep a fifth of the combined company’s research and development workforce in the UK for five years that although "we had no obligation to make these [jobs] commitments we were willing to do so because we support the opportunity to strengthen the UK life sciences industry.

"We understand fully that they would be binding as a matter of English law."

There are fears that a takeover could see Pfizer axe thousands of jobs, and top scientists — including the provost of University College, London — have warned that medical research in the UK could be “nullified” by the deal.

But Pfizer’s president of research, Mikael Dolsten, who will be giving evidence before the science and Technology select committee on Wednesday, made the unusual move of writing a newspaper column on why the potential takeover “would benefit patients around the world and strengthen the UK’s life sciences industry”.

Writing in the Evening Standard, Dolsten, who joined Pfizer as part of its $68 billion (£40 billion) acquisition of Wyeth in 2009, wrote that as a result he can "speak from personal experience on this subject".

"[The Wyeth deal] provoked similar concerns about the impact of a big merger on scientific progress."

Dolsten claimed the US Viagra-maker has “great respect” for AstraZeneca and its heritage but a merged business would be “better placed to meet society’s demand for the faster and more cost-effective delivery of medicines”.

His attempt to woo Astra’s investors, UK politicians and this country’s scientific community comes despite no firm offer being on the table from Pfizer. AstraZeneca rejected its most recent approach.

Pfizer points out: "AstraZeneca faces difficult challenges [such as] looming patent expiries," in its select committee submissions, but does not mention its own patent cliff, with Pfizer blockbusters including cholesterol treatment Lipitor facing generic competition.

Ian Read, Pfizer’s chief executive, has recorded four videos aiming at winning support for the deal, which he claimed would be a "win win" for investors and science.

AstraZeneca chief Pascal Soriot told The Independent that AstraZeneca was healthier as an independent medicine maker: "We are creating and investing in new drugs which we believe will transform how we tackle diseases and change patients’ lives."

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
Life and Style
life
Arts and Entertainment
Cold case: Aaron McCusker and Christopher Eccleston in ‘Fortitude’
tvReview: Sky Atlantic's ambitious new series Fortitude has begun with a feature-length special
Voices
Three people wearing masks depicting Ed Miliband, David Cameron and Nick Clegg
voicesPolitics is in the gutter – but there is an alternative, says Nigel Farage
Voices
The veterans Mark Hayward, Hugh Thompson and Sean Staines (back) with Grayson Perry (front left) and Evgeny Lebedev
charity appealMaverick artist Grayson Perry backs our campaign
News
i100
News
people
ebooks
ebooksA special investigation by Andy McSmith
Sport
Chelsea manager Jose Mourinho
footballThe more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him
Life and Style
Vote green: Benoit Berenger at The Duke of Cambridge in London's Islington
food + drinkBanishes thoughts of soggy school dinners and turn over a new leaf
News
Joel Grey (left) poses next to a poster featuring his character in the film
peopleActor Joel Grey comes out at 82
News
i100
News
business
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Compliance Assistant

£13000 per annum: Recruitment Genius: This Pension Specialist was established ...

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Recruitment Genius: Technical Report Writer

£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...

MBDA UK Ltd: Indirect Procurement Category Manager

Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...

Day In a Page

Isis hostage crisis: The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power

Isis hostage crisis

The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power, says Robert Fisk
Missing salvage expert who found $50m of sunken treasure before disappearing, tracked down at last

The runaway buccaneers and the ship full of gold

Salvage expert Tommy Thompson found sunken treasure worth millions. Then he vanished... until now
Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Maverick artist Grayson Perry backs our campaign
Assisted Dying Bill: I want to be able to decide about my own death - I want to have control of my life

Assisted Dying Bill: 'I want control of my life'

This week the Assisted Dying Bill is debated in the Lords. Virginia Ironside, who has already made plans for her own self-deliverance, argues that it's time we allowed people a humane, compassionate death
Move over, kale - cabbage is the new rising star

Cabbage is king again

Sophie Morris banishes thoughts of soggy school dinners and turns over a new leaf
11 best winter skin treats

Give your moisturiser a helping hand: 11 best winter skin treats

Get an extra boost of nourishment from one of these hard-working products
Paul Scholes column: The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him

Paul Scholes column

The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him
Frank Warren column: No cigar, but pots of money: here come the Cubans

Frank Warren's Ringside

No cigar, but pots of money: here come the Cubans
Isis hostage crisis: Militant group stands strong as its numerous enemies fail to find a common plan to defeat it

Isis stands strong as its numerous enemies fail to find a common plan to defeat it

The jihadis are being squeezed militarily and economically, but there is no sign of an implosion, says Patrick Cockburn
Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action

Virtual reality: Seeing is believing

Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action
Homeless Veterans appeal: MP says Coalition ‘not doing enough’

Homeless Veterans appeal

MP says Coalition ‘not doing enough’ to help
Larry David, Steve Coogan and other comedians share stories of depression in new documentary

Comedians share stories of depression

The director of the new documentary, Kevin Pollak, tells Jessica Barrett how he got them to talk
Has The Archers lost the plot with it's spicy storylines?

Has The Archers lost the plot?

A growing number of listeners are voicing their discontent over the rural soap's spicy storylines; so loudly that even the BBC's director-general seems worried, says Simon Kelner
English Heritage adds 14 post-war office buildings to its protected lists

14 office buildings added to protected lists

Christopher Beanland explores the underrated appeal of these palaces of pen-pushing
Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Scientists unearthed the cranial fragments from Manot Cave in West Galilee